STAT | Reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

April 22, 2025

STAT Plus: Bristol’s Cobenfy disappoints as supplemental antipsychotic drug
April 22, 2025

STAT Plus: FDA Commissioner Marty Makary announces three new hires in leadership team
April 22, 2025

Short-term diet trials are designed to fail
April 22, 2025

Employers should continue waiving preventive care out-of-pocket costs regardless of how Supreme Court rules
April 21, 2025

STAT Plus: UnitedHealth discloses $1.7 million in security spending after slaying of top exec
April 21, 2025

STAT Plus: Harvard sues Trump administration over funding freeze

The 2025 STATUS List is live! View 50 changemakers shaping headlines

View the list

Food companies agree to phase out synthetic dyes, handing MAHA a victory

RFK Jr. and Marty Makary say food companies will get rid of 8 artificial food dyes by the end of 2026, a Make America Healthy Again priority.

Health April 22, 2025

STAT Plus: Women’s Health Initiative, known for hormone therapy trials, to lose federal funding

Pharmalot April 22, 2025

STAT Plus: An ‘insane’ calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates

Politics April 21, 2025

STAT Plus: NIH director calls Trump’s anti-DEI orders ‘misunderstood,’ downplays reorganization plans

Exclusive April 22, 2025

STAT Plus: Biotech entrepreneur Sam Waksal accused of ‘reckless conduct’ in new lawsuit

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: NIH bans all future grants to universities with DEI programs or Israel boycotts

STAT Plus: NIH director calls Trump’s anti-DEI orders ‘misunderstood,’ downplays reorganization plans

STAT Plus: NIH said to have halted awarding of new grants to top universities

STAT Plus: In Ireland, a global hub for the pharma industry, Trump tariffs are a source of deep worry

STAT Plus: Arkansas adopts first-in-the-nation law forcing companies to choose between running a PBM or pharmacies

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

AACR Recap: The Latest News in Cancer Science

Virtual

Catch up on the biggest news and takeaways from AACR Annual Meeting 2025 — one of the most important gatherings in oncology.

STAT Breakthrough Summit West

San Francisco, CA

Navigating Rapid Advancements in Cancer Care

Virtual

STAT@ASCO: The Future of Cancer Treatment

Chicago, IL

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

AI in health care: Opportunities, risks, and the road ahead

$39

STAT’s new report explores recent efforts to apply AI in medicine and the life sciences, and it’s consequences for health, safety, and privacy.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

Our opinion podcast discusses the people, issues, and ideas that are shaping health care.

Color Code

Our podcast raising the alarm on racial inequities in American health care.

More From STAT

Events Trackers Reports Podcasts

More Stories

Biotech April 22, 2025

STAT Plus: Bristol’s Cobenfy disappoints as supplemental antipsychotic drug

Exclusive April 22, 2025

STAT Plus: FDA Commissioner Marty Makary announces three new hires in leadership team

First Opinion April 22, 2025

Short-term diet trials are designed to fail

First Opinion April 22, 2025

Employers should continue waiving preventive care out-of-pocket costs regardless of how Supreme Court rules

Insurance April 21, 2025

STAT Plus: UnitedHealth discloses $1.7 million in security spending after slaying of top exec

In the Lab April 21, 2025

STAT Plus: Harvard sues Trump administration over funding freeze

Health April 21, 2025

U.S. Supreme Court appears likely to uphold ACA preventive care coverage mandate

Exclusive April 21, 2025

STAT Plus: NIH bans all future grants to universities with DEI programs or Israel boycotts

Health April 21, 2025

Intensive lowering of blood pressure tied to lower dementia risk

Health Care Inc. Newsletter April 21, 2025

STAT Plus: ACA marketplace worries, and a UNH stock chart

Biotech April 21, 2025

STAT Plus: Gilead says its therapy delayed growth of tumors in aggressive form of breast cancer

Biotech April 21, 2025

STAT Plus: Immunovant replaces CEO, makes other changes as Roivant tightens control

D.C. Diagnosis April 22, 2025

STAT Plus: Research grants as political ammo; Death to dyes?

Pharmalot April 22, 2025

STAT Plus: Pharmalittle: We’re reading about Trump international drug pricing, Roche to invest $50 billion in U.S. plants, and more

Pharmalot April 21, 2025

STAT Plus: Pharmalittle: We’re reading about a Novo challenge to Medicare talks, a scuttled FDA office, and more

Politics April 21, 2025

STAT Plus: When should six drugs count as one? The answer could be a big deal for pharma companies

Pharma April 21, 2025

STAT Plus: In Ireland, a global hub for the pharma industry, Trump tariffs are a source of deep worry

In the Lab April 18, 2025

STAT Plus: NIH said to have halted awarding of new grants to top universities

First Opinion April 22, 2025

Short-term diet trials are designed to fail

First Opinion April 22, 2025

Employers should continue waiving preventive care out-of-pocket costs regardless of how Supreme Court rules

First Opinion April 21, 2025

Physician groups need to become better advocates

First Opinion April 21, 2025

Trump’s mental health and addiction problem

First Opinion April 18, 2025

I don’t know what I’m supposed to call my rare kidney disease

First Opinion April 18, 2025

Five priorities to remake the FDA in a time of deep uncertainty

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

For an Air Force vet, an FDA layoff brings back symptoms of PTSD

By Eric Boodman

STAT Plus: ‘The same Bobby Kennedy’: How RFK Jr.’s vaccine criticism came rushing back

By Daniel Payne

STAT Plus: Inside U.S. health agencies, workers confront chaos and questions as operations come unglued

By STAT Staff

Why CDC cuts are being called ‘the greatest gift to tobacco industry in the last half-century’

STAT Plus: Debate over soda, candy bans shows how MAHA is scrambling old alliances

STAT Plus: HIV prevention was making great strides. Then Trump’s budget axe fell

STAT Plus: Cancer research, long protected, feels ‘devastating’ effects under Trump

STAT Plus: RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’

By O. Rose Broderick

STAT Plus: GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

Biotech April 17, 2025

STAT Plus: GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

Biotech April 14, 2025

STAT Plus: How a downturn in biotech may be felt in Kendall Square, an industry hub

Biotech April 14, 2025

STAT Plus: Verve gene-editing therapy lowers cholesterol without serious side effects in early study

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot April 18, 2025

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot April 18, 2025

STAT Plus: Pharmalittle: We’re reading about FDA layoffs hurting user fee programs, pharma tariffs, and more

Pharmalot April 17, 2025

STAT Plus: Pharmalittle: We’re reading about Lilly’s weight loss pill, biotechs hurt by FDA layoffs, and more

Advanced cancers returned to pre-pandemic levels, according to a reassuring report

Health April 22, 2025

Advanced cancers returned to pre-pandemic levels, according to a reassuring report

Health April 17, 2025

In Braidwood v. Kennedy, Supreme Court is hearing challenge to ACA rule requiring free preventive care

Health April 16, 2025

Vaccine advisory panel recommends expanded RSV use, and two new vaccines

STAT Plus: Medical journal receives U.S. attorney letter seeking information about alleged bias

Politics April 18, 2025

STAT Plus: Medical journal receives U.S. attorney letter seeking information about alleged bias

Politics April 18, 2025

STAT Plus: White House trumpets Covid lab leak theory on web page that was devoted to health information

Politics April 18, 2025

STAT Plus: Health care industry, worried millions could lose ACA insurance, pushes for Trump to delay changes

Video

The end-of-life doula: Making smooth the paths of people on the journey to death

Health Care’s Colossus: Inside STAT’s investigations of UnitedHealth

STAT Plus: Why is health care cybersecurity so bad?

STAT Plus: Inside the telehealth-fueled GLP-1 alternative market

FDA

FDA

STAT Plus: In directives to federal agencies, Trump charts a different course for AI

Health tech April 18, 2025

STAT Plus: In directives to federal agencies, Trump charts a different course for AI

Health tech April 17, 2025

STAT Plus: To speed adoption of breast cancer AI, a radiology network plots an acquisition

Health tech April 16, 2025

STAT Plus: Device maker that helped UnitedHealth collect billions offers to settle fraud claims with DOJ

STAT Plus: Harvard urges researchers to limit spending, cease hiring if projects are affected by Trump funding freeze

In the Lab April 16, 2025

STAT Plus: Harvard urges researchers to limit spending, cease hiring if projects are affected by Trump funding freeze

In the Lab April 15, 2025

STAT Plus: Harvard scientist ordered to halt multicenter TB trial in funding freeze

In the Lab April 8, 2025

STAT Plus: With Trump review, a Harvard infectious disease researcher stands to lose it all

STAT Plus: Harvard funding cuts will largely spare affiliated hospitals, Trump administration says

Hospitals April 15, 2025

STAT Plus: Harvard funding cuts will largely spare affiliated hospitals, Trump administration says

Hospitals April 1, 2025

STAT Plus: ‘We are all terrified’: Mass General Brigham to lose millions in medical research grants under Trump cuts

Hospitals March 18, 2025

STAT Plus: Congress created a unique plan to save rural hospitals — but few are using it

STAT Plus: UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care

Insurance April 17, 2025

STAT Plus: UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care

Insurance April 7, 2025

STAT Plus: Study shows how UnitedHealth uses coding to rake in extra cash from Medicare Advantage

Insurance April 1, 2025

Prosecutors directed to seek death penalty against UnitedHealthcare killing suspect Luigi Mangione

Podcasts

Why cats are so vulnerable to H5N1 bird flu

BIO’s John Crowley on RFK Jr. and tariffs, plus calls for more federal biotech funding

The invisibility of good public health work

Cuts, ousters and drama at the FDA